Stifel's Head of Therapeutics Research Paul Matteis shares his take on biotech and discusses companies he covers that have been in the news

0:00-12:37

He discusses Biogen, Alnylam, Xenon, and Compass Pathways

B-

BiotechTV - News

@biotechtvnews

#stifelshead #therapeuticsresearchpaul #discussescompanies #lifesciences

The Nile